中文 | English
Return
Total: 78 , 1/8
Show Home Prev Next End page: GO
Author:(Shao-yong SHEN)

3.Analysis of the treatment and prognostic factors of hepatic metastases of colorectal cancer:a report of 52 cases

Guangrong CAI ; Xianglin SHAO ; Yong LI ; Rengang SUN ; Baozhong SHEN

Chinese Journal of General Surgery 1993;0(03):-

4.Clinical and imaging features and infarct pattern analysis in patients with middle cerebral artery stenosis and occlusion

Yong SHAO ; Jie CHANG ; Zhenfang ZHU ; Hong SHEN

Chinese Journal of Primary Medicine and Pharmacy 2011;18(19):2629-2631

5.The effects of serum glycodelin-A on pregnancy outcome in women receiving intrauterine insemination

Meiling LI ; Yuanjiao LIANG ; Tao SHEN ; Yong SHAO ; Jun JING ; Bing YAO

Journal of Medical Postgraduates 2014;(12):1294-1296

6.COMPARISON OF GUIZOTIA ABYSSINICA SEED AGAR WITH CAFFEIC ACID CORNMEAL AGAR TO SELECTIVELY ISOLATE CRYPTOCOCCUS NEOFORMANS

An-Sheng LI ; Guei-Xia LU ; Yong-Nian SHEN ; Wei CHEN ; Shao-Xi WU ;

Microbiology 1992;0(05):-

7.Preliminary study on determination of specific cellular immunity of patients with hepatitis B.

Jing HE ; Shao-jie XIN ; Hong-hui SHEN ; Jian-yang YANG ; Lei ZHU ; Yan HU ; Jun HOU ; Pan-yong MAO

Chinese Journal of Experimental and Clinical Virology 2006;20(1):33-35

8.HPLC-ESI/MS analysis of stachydrine and its metabolites in rat urine.

Huai-Xia CHEN ; Shao-Lin SHEN ; Feng-Mei HAN ; Yong CHEN

Acta Pharmaceutica Sinica 2006;41(5):467-470

9.Quality control of shuanghuanglian freeze-dried powder for injection based on its HPLC-ELSD fingerprints and biological profiles.

Ya-Ming ZHANG ; Dan YAN ; Ping ZHANG ; Yong-Shen REN ; Shao-Feng ZHANG ; Xue FENG ; Xiao-He XIAO

Acta Pharmaceutica Sinica 2010;45(1):93-97

10.Analysis of ephedrine and its metabolites in rat urine by HPLC-ESI-ITMSn.

Yong CHEN ; Shao-Lin SHEN ; Huai-Xia CHEN ; Feng-Mei HAN

Acta Pharmaceutica Sinica 2005;40(9):838-841

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 78 , 1/8 Show Home Prev Next End page: GO